Compare Novartis AG (NVS) vs Synchrony Financial (SYF) Price & Performance

Novartis AGTrade

Synchrony FinancialTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Synchrony Financial — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Synchrony Financial trades at $71.7 (market cap $24.69B). The key difference: Novartis AG is far larger — about 11.8× Synchrony Financial's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

	NVS	SYF
Market Cap	$290.25B	$24.69B
Sector	Health	Financials
52-Week High	$168.62	$88.47
52-Week Low	$113.50	$63.78
Enterprise Value	$330.27B	—
Dividend Yield	3.17%	1.63%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

SYF

Consumers keep spending frequently despite inflation, boosting Synchrony's Q2 purchase volume 8%.PYMNTS · 7 hours agoBullish Synchrony Financial declares $0.34 quarterly dividend per common share, payable August 17, 2026.PRNewsWire · 16 hours agoNeutral View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Synchrony Financial

Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.